Top News

Research News

Faculty and Staff News


Partner News

Top News

  • IU School of Medicine receives $30 million NIA grant for Alzheimer’s and related dementia research

    The National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) grant has been renewed for another five years with funding expected to total $30 million from the National Institute on Aging, within the National Institutes of Health. The NCRAD, located at IU School of Medicine, has been continuously funded since 1990. Since 2018, the NCRAD grant has been among the five largest grants awarded to IU School of Medicine.

    “National Centralized Repository for Alzheimer’s Disease and Related Dementias serves as the primary resource for samples for all NIA-funded dementia studies,” said  Tatiana Foroud, PhD, executive associate dean for research affairs at IU School of Medicine, who leads NCRAD and who is also the chair for the department of medical and molecular genetics at IU School of Medicine. “In the next five years, our recruitment efforts will focus on engaging diverse communities to obtain a broad range of samples from individuals who represent the diversity of populations that make up our nation and our world.”

    NCRAD supports research about causes, early detection and therapeutic development for Alzheimer’s and other dementias. The repository is home to more than a million biological samples, including DNA, plasma, brain tissue and cell lines. These samples assist scientists in conducting a variety of Alzheimer’s and dementia research, such as the development of blood-based biomarker tests, which are less expensive and invasive than other methods for early detection of dementias, such as PET scans and testing of cerebrospinal fluid. 

    Visit the Newsroom for more details on the repository and the most recent research funding.

    Back to Top ▲

  • Emergency Medicine earns national award for wellness efforts during COVID-19

    The IU School of Medicine Department of Emergency Medicine has received the 2021 Emergency Medicine Wellness Center of Excellence Award from the American College of Emergency Physicians (ACEP) for work to promote wellness for its faculty, fellows, residents and staff throughout the COVID-19 pandemic. The national award was given to one emergency medicine department in the country for demonstrating an outstanding commitment to developing aspects of well-being for emergency physicians.

    “When the pandemic started in March 2020, we had to respond quickly and strategically to the crisis as a frontline clinical department,” said Julie Welch, MD, vice chair of faculty development. “The Incident Command System leadership team recognized the importance of wellness and incorporated it as a priority from the beginning.”

    For details on the department’s recent honor, visit the Newsroom.

    Back to Top ▲

  • Department of Mental Health Services launches new website

    Same URL. New content. Better experience. The IU School of Medicine Department of Mental Health Services has recently launched a new website. Redesigned to improve the user experience and make relevant information more accessible, the new layout delivers quick links to learner resources, including the new Mental Health Services Learner Portal, campus-specific mental health resources and crisis contacts. 

    Additionally, the website now includes helpful reference materials such as presentations, mental health screenings and information regarding common mental health concerns.

    Back to Top ▲

  • Nominate colleagues for staff awards

    After being postponed last year due to the pandemic, nominations for IU School of Medicine staff awards are now being accepted. These awards provide a visible and powerful way to honor the behaviors, achievenments and outcomes that are most important to advancing the school.

    Check out award descriptions, guidelines and previous winners for the following:

    Deb Cowley Staff Leadership Award
    Lynn Wakefield Unsung Hero Staff Award
    Outstanding Staff Commitment to Diversity Award

    Back to Top ▲

  • Masks now optional for fully vaccinated on all IU campuses

    IU faculty, staff and students are stepping up in extraordinary numbers to receive COVID-19 vaccinations to protect themselves and the IU community.

    As a result of the reduced incidence of COVID-19 and enhanced safety across university campuses resulting from these high vaccination rates, masks are now optional for anyone who is fully vaccinated. This applies to all IU campuses, including IUPUI, all regional campuses, IUPUC and IU Fort Wayne.

    “The available COVID-19 vaccines continue to prove their high level of effectiveness in protecting fully vaccinated individuals from contracting the virus, especially protecting them from becoming ill if they do,” said Aaron Carroll, MD, IU’s chief health officer and faculty member at IU School of Medicine. “Those fully vaccinated are also at lower risk of passing it to others. This, along with the amazing response from our students, faculty and staff in getting vaccinated, makes the time right to change the university's mask policy.”

    IU continues to ask individuals who are not yet fully vaccinated to wear masks inside buildings on campus. All individuals, regardless of vaccination status, will need to continue to wear masks on campus buses per guidelines from the federal Transportation Security Administration.

    For more information about fall 2021 on IU campuses, visit News at IU.

    Back to Top ▲

Research News

  • June research awards total over $16 million

    Investigator Sponsor Type Project Title Begin Date End Date Awarded Dollars
    Matthew R Allen National Institute Of Diabetes, Digestive & Kidney New Chronic kidney disease effects on cortical bone porosity and mechanics with age 6/23/2021 5/22/2022 $39,072
    Robert L Bacallao Dialysis Clinic, Inc New AMOT-polycystin 1 interaction in the apical polarity complex. 6/1/2021 5/31/2022 $100,000
    Naro Biswas Grace M. Showalter Trust New Targeting BAFF for modulation of adaptive immune responses to factor VIII replacement therapy 7/1/2021 6/30/2022 $74,998
    Natalia V Bogatcheva Grace M. Showalter Trust New Small-molecule dual PARP1-PDL1 inhibitor as a mitigator of influenza-induced lung injury. 7/1/2021 6/30/2022 $75,000
    Malaz A Boustani Regenstrief Institute, Inc. New The Delivery of Objective Sleep Evidence (DOSE) Study 4/8/2021 8/31/2022 $371,462
    Alan Breier Eskenazi Health New The Prevention and Recovery Center (PARC) for Early Psychosis Coordinated Specialty Care 9/1/2020 9/30/2021 $105,165
    Zhenhui Chen Cedars-sinai Medical Center New SK current and ventricular arrhythmias. 3/15/2021 11/30/2021 $89,079
    Arupratan Das Grace M. Showalter Trust New Use of Human stem cell derived Retinal Ganglion Cells to investigate Nrf2 as therapeutic target for glaucomatous optic neuropathy 7/1/2021 6/30/2022 $75,000
    Zeruesenay Desta Virginia Polytechnic Institute & State University New Repurposing Auranofin and Ebselen for Treatment of Multidrug Resistant Pathogens 4/30/2021 3/30/2022 $40,715
    Balamurugan Dhayalan Diabetes Research Connection New Engineered Dual Insulin-Glucagon Agonist as a Novel Ultra-Stable GRI System 7/1/2021 6/30/2022 $50,000
    Dom Doster Association Of Program Directors In Surgery New Defining the Competent General Surgery Intern and Identifying Metrics of Graduating Medical Student Aptitude Predictive of Achieving Intern-Level Competency 5/4/2021 5/3/2023 $29,681
    Howard J. Edenberg Washington University New 7/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact 4/1/2021 1/31/2022 $197,076
    Carmella Evans-Molina Riley Children's Foundation New George and Frances Ball Foundation 3/1/2021 2/28/2022 $50,000
    Carmella Evans-Molina University Of Florida Renewal (not prev committed) Network for Pancreatic Organ Donors - nPOD 4/1/2021 3/31/2022 $13,719
    Martin Rhys Farlow University Of Southern California New AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Intermediate Amyloid (A3 Trial) 1/1/2020 12/31/2021 $1,591,544
    Melissa L Fishel National Cancer Institute New Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors 6/1/2021 5/31/2022 $448,088
    Tatiana M Foroud University Of California, San Diego New A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ912 (varoglutamstat) in Patients with Early Alzheimer¿s Disease 1/1/2021 12/31/2021 $309,646
    Tatiana M Foroud Broad Institute Renewal (not prev committed) Schizophrenia Spectrum Biomarkers Consortium (SSBC) Pilot 7/1/2021 6/30/2022 $122,166
    Tatiana M Foroud Banner Alzeheimer's Institute New APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease 11/1/2020 6/30/2021 $177,948
    Nicole R Fowler Grace M. Showalter Trust New Showalter Scholar - Nicole Fowler 7/1/2021 6/30/2022 $25,000
    Benjamin Gaston National Heart, Lung And Blood Institute New First meeting of the international collaborative asthma network 6/15/2021 5/31/2022 $10,000
    Subhadip Ghatak National Institute Of Diabetes, Digestive & Kidney New Exosomes in wound healing 7/1/2021 6/30/2022 $118,875
    Debra Hickman American College Of Labortory Animal Medicine New Evaluation of the well-being of aging male Sprague Dawley rats in a variety of commercially available individually ventilated caging systems 7/1/2021 6/30/2022 $30,000
    Debra Hickman Am Assn For Laboratory Animal Science New Evaluation of the well-being of aging male Sprague Dawley rats in a variety of commercially available individually ventilated caging systems 7/1/2021 11/30/2022 $34,058
    JoAnna Lee Hunter-Squires Intuitive Foundation New AMPATH Surgical APP (ASAP) 1/26/2021 10/31/2021 $200,000
    Danielle Janosevic Grace M. Showalter Trust New The study of transcription and translational mediators of sepsis-associated kidney injury in the diabetic milieu. 7/1/2021 6/30/2022 $75,000
    Chandy C John Riley Children's Foundation New Riley Relief Research Funding - COVID Research Funding 6/1/2020 6/30/2021 $160,102
    Martin Kaefer University Of North Carolina At Chapel Hill New Testing the usability of a web-based hypospadias decision aid for parents using a user-centered design approach 4/15/2021 4/14/2022 $118,875
    Reuben Kapur Riley Children's Foundation Renewal (not prev committed) Hamer Funds for Oncology 6/1/2021 6/30/2022 $153,999
    Savita Khanna Ohio State University New In vivo characterization of epigenetic mediated, sepsis-related immunosuppression 11/1/2020 6/30/2021 $60,000
    Jacquelyn D Lajiness American Academy Of Pediatrics New Maternal lipids regulate neonatal dendritic cells during development of allergic disease 7/1/2021 6/30/2022 $5,000
    Brian David Leland Columbia University New Pediatric ICU Continuity Strategies Conference and Guidelines Formulation 4/1/2021 3/31/2022 $62,393
    Ping Li National Institute Allergy & Infectious Diseases New Development of novel strategies to modulate human NK cell response in xenotransplantation 5/21/2021 4/30/2022 $237,750
    Suthat Liangpunsakul So California Institute For Research And Education Renewal (not prev committed) Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study 7/1/2020 6/30/2021 $128,506
    Kenneth Lim Grace M. Showalter Trust New The Myocardial Cytoskeleton in Chronic Kidney Disease (CKD) 7/1/2021 6/30/2022 $75,000
    Patrick J. Loehrer National Cancer Institute New The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS 9/7/2020 8/31/2021 $995,284
    Americo Harry Lopez-Yglesias American Heart Association Incorporated New T-bet-regulated innate defense against the heart parasite Toxoplasma gondii 7/1/2021 6/30/2024 $231,000
    Troy A Markel Nec Society New Biomarkers for Necrotizing Enterocolitis 6/1/2021 3/31/2022 $7,500
    Troy A Markel Gerber Foundation New Volatile Organic Compound Profiling to Predict Risk of Necrotizing Entercolitis 6/7/2021 6/6/2024 $348,909
    Megan Song McHenry National Institute Of Child Health, Human Devl. New Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya 4/9/2021 1/31/2022 $671,758
    Anirban Kumar Mitra American Cancer Society, Incorporated New Microenvironment mediated regulation of ovarian cancer metastasis by ETS1 7/1/2021 6/30/2025 $792,000
    Kenneth P Nephew University Of Arkansas For Medical Sciences New The Genomic, Epigenomic, and Quality-of-Life Characteristics of Long-Term Survivors of Ovarian Cancer 3/15/2021 12/25/2022 $244,010
    Alexander G Robling National Institute On Aging New Targeting multiple Wnt inhibitors for synergistic anabolic action in the skeleton 4/1/2021 3/31/2022 $35,458
    Stephen Schlecht Grace M. Showalter Trust New Does the timing of ACL reconstructive surgery have an impact on long-term autograft outcomes? 7/1/2021 6/30/2022 $74,473
    Chandan K Sen National Institute Of Diabetes, Digestive & Kidney New Tissue reprogramming in diabetic wound healing 5/1/2021 4/30/2022 $481,477
    Jason Michael Spaeth Grace M. Showalter Trust New Dynamic regulation of Pdx1 and islet ß-cell function by the Nucleosome Remodeling and Deacetylase complex 7/1/2021 6/30/2022 $75,000
    Stephanie Marie Stahl American Academy Of Sleep Medicine Foundation New AASM Sleep Medicine Fellowship Funding Award 7/1/2022 6/30/2023 $90,540
    William J. Sullivan Grace M. Showalter Trust Renewal (not prev committed) Disrupting RNA modification as a novel treatment for parasitic infection 7/1/2021 6/30/2022 $60,000
    Steven P Templeton National Institute Allergy & Infectious Diseases New Regulation of Inflammatory Pathology in Invasive Aspergillosis 6/11/2021 5/31/2022 $157,500
    Angela M Tomlin Health Resources And Services Administration Renewal (not prev committed) Interdisciplinary Leadership Education 7/1/2021 6/30/2022 $623,558
    John J Turchi National Cancer Institute New Novel DNA damage response therapeutics targeting replication protein A 7/1/2021 6/30/2022 $509,008
    Jonah Vilseck Grace M. Showalter Trust New Accelerating Structure-Based Lead Optimization with AI-Inspired Molecular Generation And Fast Free Energy Calculations 7/1/2021 6/30/2022 $75,000
    Ting Wang Sigma Xi, The Scientific Res Society New Mechanistic understanding of Clusterin as an intraocular pressure regulator via lipid-dependent pathway 6/1/2021 5/31/2022 $2,500
    Michael A. Weiss Leona M. And Harry B. Helmsley Charitable Trust New Molecular Design and Testing of Glucose-Responsive Insulins and Glucose-Responsive Glucagons 7/1/2021 6/30/2023 $1,490,034
    Ronald C. Wek Grace M. Showalter Trust Renewal (not prev committed) Translation and Stress Regulatory Pathways in Health and Disease 7/1/2021 6/30/2022 $60,000
    Kara K Wools-Kaloustian National Institute Allergy & Infectious Diseases Renewal (not prev committed) East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium 8/1/2021 5/31/2022 $3,300,000
    Yu-Chien Wu Grace M. Showalter Trust New Showalter Scholar - Yu-Chien Wu 7/1/2021 6/30/2022 $25,000
    Lei Yang Grace M. Showalter Trust New Showalter Scholar - Lei Yang 7/1/2021 6/30/2022 $25,000
    Xue Yuan National Institute Of Dental Craniofacial Research New Role of Wnt-responsive cells in oral mucosa homeostasis, injury, and malignancy 6/1/2021 5/31/2022 $248,972
    Yong Zang Grace M. Showalter Trust New Transparent and efficient dose-finding clinical trial designs for targeted therapies and immunotherapy 7/1/2021 6/30/2022 $74,297
    Ji Zhang Grace M. Showalter Trust New Regulation of iron-dependent histone demethylation by amino acid starvation. 7/1/2021 6/30/2022 $75,000
    Xinna Zhang Grace M. Showalter Trust New IDENTIFICATION OF EPIGENETIC INHIBITORS TO SENSITIZE TNBC TO IMMUNOTHERAPY 7/1/2021 6/30/2022 $75,000

    Back to Top ▲

  • IU School of Medicine increases publications in high-impact journals

    Publication in high-impact scientific journals means IU School of Medicine researchers are advancing various fields of study, are highly regarded and are focused on high-quality science. These points are underscored by a significant increase in the number of publications authored by school researchers that appeared in these journals in 2020. Of the 3,500 papers published by school scientists in 2020, 402 appeared in high-impact journals. This number is up from 324 in 2019.

    Check out these recent publications in high-impact journals:

    IU School of Medicine research team discovers drug target, pathway for treating muscle fat wasting in pancreatic cancer patients

    IU School of Medicine researchers discover promising new way to prevent, treat kidney infections

    IU School of Medicine researchers develop computer program to predict whether patients could be at high risk for Alzheimer’s and cancer

    Back to Top ▲

  • Yale School of Medicine dean named winner of Watanabe prize

    Nancy J. Brown, MD, is this year’s winner of the August M. Watanabe Prize in Translational Research and will be honored at the 2021 Indiana Clinical and Translational Sciences (CTSI) Annual Meeting on Friday, September 24. She is currently the Jean and David W. Wallace Dean of Yale School of Medicine.

    Brown has led a translational research program that focuses on developing new pharmacological approaches to prevent vascular disease in patients with high blood pressure and diabetes. Her research has defined the molecular mechanisms through which commonly prescribed blood pressure and diabetes drugs affect the risk of cardiovascular and kidney disease. In her clinical practice, she has treated patients with resistant and secondary forms of hypertension.

    The Watanabe Prize is one of the nation’s largest and most prestigious awards recognizing individuals focused on shepherding scientific discoveries into new therapies for patients. It is named in honor of the late August Watanabe, a titan in the field of translational research in both academia and industry, who impacted the health of people around the world as a leader at IU School of Medicine and Eli Lilly and Company.

    Visit Indiana CTSI for more details on Brown and past winners of the Watanabe prize.

    Back to Top ▲

  • IU researchers pioneering noninvasive techniques for neurological conditions

    IU School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury, epilepsy, Parkinson’s disease, Alzheimer’s disease and more.

    “Given the increasing use of brain stimulation in human brain study and treatment of neurological diseases, this research can make a big impact on physicians and their patients,” said Xiaoming Jin, PhD, associate professor of anatomy, cell biology and physiology.

    When someone experiences a brain injury, nerve injury or neurodegeneration, such as in epilepsy and TBI, there is damage to the brain which can lead to loss and damage of nerves or neurons and development of hyperexcitability that underlies some neurological disorders such as neuropathic pain and epilepsy.

    “The conventional treatment is mainly to try to directly inhibit such hyperexcitability,” Jin said, “but we found the initial damage of the brain or nerve system was caused by a loss of brain tissue, which causes the nervous system to compensate for loss of function by working harder, so we need to stimulate activity instead of inhibit it.”

    The technique, described in a newly published paper in Neurotherapeutics, uses a new type of magnetoelectric nanoparticles that can be delivered to a specific part of the brain using a magnetic field. After, a magnetic wave can be emitted to stimulate neural activity in that particular part of the brain. The method is noninvasive, good for stimulating deep brain function and is more efficient than traditional methods of brain stimulation, without the need for genetic manipulation.

    Read more about the new technique in the Newsroom.

    Back to Top ▲

  • Researchers study anxiety differences between females and males

    Researchers from IU School of Medicine recently studied the behaviors associated with anxiety—published in Psychopharmacology—examining how biological factors impact anxiety disorders, specifically in females. They found that anxiety in females intensifies when there’s a specific, life-relevant condition.

    The team, led by Thatiane De Oliveira Sergio, PhD, postdoctoral fellow in the laboratory of Woody Hopf, PhD, professor of psychiatry and primary investigator at Stark Neurosciences Research Institute, studied male and female rodent models to better understand sex differences in biological responses related to anxiety.

    Anxiety disorders occur twice as often in women than men, and social and cultural factors likely play an important role in the development of anxiety in females, De Oliveira said. 

    The COVID-19 pandemic heavily influenced anxiety in people. According to the Centers for Disease Control and Prevention, in June 2020—a few months into the pandemic—13 percent of Americans started using or increasing substance use to cope with their emotions and stress due to the unknowns at that time about the pandemic.

    Knowing that women have more incidence of anxiety than men, De Oliveira said the roles for many women have amplified during the pandemic—working remotely, teaching children in virtual school, everyday tasks, errands. She said these life-relevant conditions could have increased their anxiety.

    “This work is giving us a foundation to start and explore anxiety behaviors that are very important and even more relevant now,” De Oliveira said.

    Visit the Newsroom to learn more.

    Back to Top ▲

Faculty and Staff News

  • Remembering Craig Gosling

    Craig Gosling, former director of the IU School of Medicine Department of Medical Illustration and Visual Media, passed away on Sunday, July 11. Gosling created hundreds of medical illustrations for the school’s medical and surgical faculty. These illustrations defined medical and surgical procedures and were used to educate and instruct faculty, fellows, residents and medical students. The illustrations were used in medical textbooks, journals and presentations.

    Gosling graduated from the accredited program of Medical Illustration at the University of Illinois College of Medicine in Chicago in 1965 and soon after joined IU School of Medicine. He became department director in 1974 and increased the services of the department to help with the school’s mission of education, clinical care and research.

    Gosling was a pioneer in the development and creation of teaching models and patient simulators. His work was so innovative that the designs were purchased from IU School of Medicine by anatomical companies as protypes for new models. The teaching models were used by faculty to show medical conditions and how to determine a prognosis from interaction with the model. He also designed and implemented a course for residents and fellows that helped increase their observation and communication skills when interacting with patients. The main objective of the course was to improve drawing skills so the residents would be able to more fully explain reconstructive procedures to patients.

    An obituary was not available at the time of publication.

    IU and IU School of Medicine offer support for the school community. IU Employee Assistance Program (EAP) provides 24/7/365 access to licensed mental health counselors via SupportLinc. The IU School of Medicine Department of Mental Health Services provides emergency help 24 hours a day, seven days week by calling 317-278-HELP (4357).

    Back to Top ▲

  • ICYMI: A message from Indiana University President Pamela Whitten

    Pamela Whitten assumed the role of president of Indiana University on July 1. She sent the following message to IU faculty and staff earlier this week.

    Dear colleagues, 

    Thank you for the warm welcome as I take on the role of president for Indiana University. In these first days of my transition, I am witnessing firsthand what you already know. IU is an exceptional university with extraordinary opportunities. Your passion for IU is inspiring, and I appreciate the input you are sharing for our collaborative future.

    Our collective IU spirit will be pivotal as we navigate a return to normalcy in the coming fall semester. IU employed world-class clinical advice to navigate safely during the pandemic. This sound approach will continue to be applied as we emerge from this pandemic. As we ramp down from the activities that kept us safe during COVID-19, we will continue to monitor any changes and adjust as necessary to ensure that we keep Indiana University safe and healthy.

    During my first weeks in Indiana, things may seem quiet from my office as I focus on listening and learning. Once we come together to launch the fall semester, I plan to communicate directly through a weekly message to the IU community. 

    Enjoy the remaining days of summer with family and friends. I look forward to joining you all in the privilege and joy of welcoming our students back to each of our IU campuses for the fall semester.

    Visit Office of the President to learn more about Whitten and her first days as IU president.

    Back to Top ▲

  • Neal, Smartt and Reeser take on new roles in Educational Affairs

    Matthew Neal, Karen Smartt and Marti Reeser have new titles or roles within the IU School of Medicine Office of Educational Affairs.

    Matt Neal, MD, MBA, to serve as assistant dean in graduate medical education
    Neal has served five years as assistant dean for faculty development in Faculty Affairs, Professional Development and Diversity. He will now serve as assistant dean in graduate medical education and work in the area of IU School of Medicine GME expansion.

    Karen Smartt, EdD, promoted to assistant dean and director of the Admissions Office
    Smartt has served as the director of admissions at IU School of Medicine. She began employment with the medical school in December of 1999 as the associate director of admissions specializing in diversity recruitment. As a result of her diversity recruitment efforts, IU School of Medicine has been ranked among the nation’s top programs for underrepresented medical student enrollment.

    Marti Reeser, EdD, promoted to associate dean for health professions and pre-doctoral programs and associate dean for academic records and promotion
    Reeser earned both a Master of Science in Education with a focus in College Student Personnel Administration and a Doctor of Education with a focus in Higher Education Administration from IU.

    Back to Top ▲

  • DEI resource series: View a webinar on cultural humility

    What is cultural humility and what role does it play today? The IU Office of the Vice President for Diversity, Equity, and Multicultural Affairs hosted a webinar on cultural humility that sheds light on this concept and its importance. View the webinar.

    Back to Top ▲


  • Tomorrow: AMPATH Fireside Chat to feature Spencer and Einterz

    Join Jesse Spencer, actor and star of NBC’s Chicago Fire, as he interviews Bob Einterz, MD, on the transition from AMPATH co-founder to leader of South Bend's Department of Health in northern Indiana. The enlightening conversation about how global health is local health takes place Friday, July 16, at noon (ET), via Zoom. Get more details and register

    Back to Top ▲

  • July 27 “Simon Says” to focus on coping with fear of cancer recurrence

    The next Simon Says event, “Waiting for the Other Shoe to Drop: Coping Effectively with Fear of Cancer Recurrence,” will be at noon on Tuesday, July 27.

    Fear of recurrence is one of the most common and disruptive sources of distress during cancer survivorship. Even when recurrence risk is low, many survivors struggle with this understandable concern. IU Simon Comprehensive Cancer Center researcher Shelley Johns, PsyD, who studies fear of recurrence, will discuss how her research seeks to support survivors in coping effectively when struggling with anxiety related to “waiting for the other shoe to drop.” IU School of Nursing Assistant Professor Andrea Cohee, PhD, also specializes in fear of recurrence and will be the moderator. Register for the event.

    Back to Top ▲

  • August 16 event highlights taking and teaching the sexual health history

    IU School of Medicine Faculty Affairs, Professional Development and Diversity will host “Talking about Sex: Taking and Teaching the Sexual Health History” at 11:45 am on Monday, August 16. Juan Carlos Venis, MD, will provide a variety of hands-on practice through a combination of interactive didactic instruction and facilitated small group case-based activities. Emphasis will be on creating a safe space for participants to discuss these evolving, intersecting and sometimes uncomfortable topics. Register for the online event.

    Back to Top ▲

  • Deadline to apply for research engagement grant is September 1

    The IU School of Medicine Research Enhancement Program is designed to stimulate research productivity at the statewide Centers for Medical Education (regional campuses), including the Bloomington Medical Sciences Program. This does not include the IUPUI campus. All full-time Center/Medical Sciences faculty, regardless of tenure status, having an appointment of assistant/associate/full professor or assistant/associate/full scientist at time of submission, are eligible to apply for a research enhancement grant. Primary appointment must be in the school of medicine. Faculty in visiting ranks are not eligible for funding through this mechanism. Deadline to apply is Wednesday, September 1. Get application details.

    Back to Top ▲

  • Apply by September 1 for biomedical research grant

    The Biomedical Research Grant Program is open to all IU School of Medicine faculty who are full-time, regardless of tenure status, having an appointment of assistant/associate/full professor and assistant/associate/full scientist. In general, two categories of research projects will benefit from this program: 1) research projects of investigators new to IU School of Medicine who do not yet have extramural funding and who need support to acquire the preliminary data necessary to compete for extramural funding; 2) research projects of established IU School of Medicine investigators who are between funding periods from extramural sources. Application deadline is Wednesday, September 1. Find out more.

    Back to Top ▲

  • Save the date: Medical Miles Fun Run & Walk is October 23

    The IU School of Medicine Department of Family Medicine will host the third annual Medical Miles Fun Run & Walk from 9-11 am on Saturday, October 23. The event will be held at the Indianapolis downtown canal.

    Plan to join the IU community, colleagues, family and friends for this great morning of fitness. Portions of the proceeds will support the medical student outreach clinic affiliated with the Department of Family Medicine. Sign up today to lock in your position at the starting line.

    Back to Top ▲

Partner News

  • Indiana CTSI hires former Lilly leader as its new chief operating officer

    Michelle Shwery, MS, MBA, former senior director at Eli Lilly and Company has been named chief operating officer for the Indiana Clinical and Translational Sciences Institute (CTSI).

    During her more than 25-year career at Lilly, Shwery held a variety of global leadership roles in research and development, enterprise risk management, compliance and operations. Her expertise has focused on working across organizational silos, disparate groups and cultures to support success at collective and individual levels.

    “Michelle has a deep understanding of how to reconcile processes and goals across multiple programs to unify approaches,” said Sharon Moe, MD, co-director of the Indiana CTSI. “This is very valuable experience to our Indiana CTSI which works through many programs across the translational research spectrum to enable therapeutic discovery, development and implementation for patients and the broader statewide population.”

    “Michelle has deep operations experience that is also quite diverse,” said Sarah Wiehe, MD, MPH, co-director of the Indiana CTSI. “She is also very personable and relatable with a thoughtful approach to work across a variety of stakeholders, which makes her a good fit within our Indiana CTSI culture.”

    For more on Shwery’s appointment, visit Indiana CTSI.

    Back to Top ▲

  • Katzenellenbogen named co-leader of IUSCCC Cancer Prevention and Control research program

    Rachel Katzenellenbogen, MD, has been named a co-leader of the Cancer Prevention and Control research program at the IU Simon Comprehensive Cancer Center. She serves along with Susan Rawl, PhD, and Todd Skaar, PhD. Katzenellenbogen is the chief of the Division of Adolescent Medicine in the Department of Pediatrics, associate professor of pediatrics and of microbiology and immunology, and the Richard E. and Pauline P. Klingler Scholar in Pediatrics at IU School of Medicine, and the Chuck and Tina Pagano Scholar at the cancer center.

    Back to Top ▲

  • Masks required to ride on IU Health downtown shuttles

    As a form of public transportation, the IU Health downtown shuttle service requires all passengers and drivers to wear a face mask while boarding, disembarking and throughout the duration of their travel on the shuttle, regardless of vaccination status. 

    This regulation follows the United States Department of Transportation (USDOT) mask mandate, which requires the wearing of masks to prevent spread of the virus that causes COVID-19. The Center for Disease Control (CDC) issued this order on January 29, 2021, which the USDOT extended until Monday, September 13, 2021.

    Back to Top ▲